Antibiotic Treatment Regimen for Bloodstream Infections Can Safely Be Cut by Half

A seven-day course of antibiotics for hospitalized patients with bloodstream infections is just as effective as a 14-day course, according to new findings presented at IDWeek 2024. 

Bird Flu Found in Wastewater Before Reported Outbreaks

Bird flu was detected in wastewater before the first reported outbreak among Texas dairy cattle in 2024, according to new findings presented at IDWeek 2024.

Preset Treatment Orders Improve Antibiotic Prescribing Practices

A new method for prescribing antibiotics improved compliance with treatment guidelines and shortened antibiotic use in children with ear infections in emergency and urgent care settings, according to new findings presented at IDWeek 2024.

Antibiotic Resistance Gene Detection Associated with Higher Rates of Mortality

A gene that enables bacteria to evade treatment was the most common and deadly among carbapenemase-producing organism (CPO) infections in a New York health system, according to new findings presented at IDWeek 2024.

Pre-Exposure Prophylaxis Access Multifaceted; Unmet Needs Remain

Black, Hispanic and Medicaid-insured populations continue to lack equitable access to pre-exposure prophylaxis, according to new findings from Gilead Sciences presented at IDWeek 2024.

IDSA Suggests New Preventive COVID-19 Agent

The Infectious Diseases Society of America has released guidelines suggesting the use of pemivibart to prevent severe COVID-19 in immunocompromised patients.

Senate Appropriations Bills Boost ID Funding, Fall Short on Workforce Needs

The Senate FY 2025 Labor, Health and Human Services and the State and Foreign Operations appropriations bills provide increased funding for some key domestic and global infectious diseases programs.

Eight Institutions Receive the IDSA Antimicrobial Stewardship Center of Excellence Designation

The eight awarded institutions have created stewardship programs led by infectious diseases-trained physicians and pharmacists that advance science in antimicrobial resistance.

Experts in Infectious Diseases to House Leaders: Address Antimicrobial Resistance

Trish Perl, MD, FIDSA, spoke on behalf of the Infectious Diseases Society of America at Thursday’s House Budget Committee roundtable on the threats of antimicrobial resistance.

House Appropriations Bill Misses the Mark on ID Programs

The House FY 2025 Labor, Health and Human Services and State and Foreign Operations appropriations bills largely flat fund antimicrobial resistance programs at FY 2024 levels even as AMR grows as a serious public health threat.

IDSA Advocacy Delivers Significant Victory for ID in Proposed Medicare Fee Schedule

The Centers for Medicare and Medicaid Services released its calendar year 2025 Medicare Physician Fee Schedule Proposed Rule July 10, including a new “add-on” code for infectious diseases developed and advocated for by IDSA. 

IDSA Releases New Guidelines for Complicated Intra-Abdominal Infections

The Infectious Diseases Society of America has released new guidelines on complicated intra-abdominal infections in children, adults and pregnant people.